Adenosine: a new drug for acute termination of supraventricular tachycardia
| Autor: | D. G. Vidt, A. W. Bakst, S. L. Pinski, J. D. Maloney |
|---|---|
| Rok vydání: | 1990 |
| Předmět: |
Drug
medicine.medical_specialty Adenosine Heart Ventricles media_common.quotation_subject Drug Administration Schedule Diagnosis Differential Internal medicine Tachycardia Supraventricular medicine Humans cardiovascular diseases Infusions Intravenous Adverse effect media_common business.industry General Medicine medicine.disease Verapamil Adenosine a cardiovascular system Cardiology Supraventricular tachycardia Differential diagnosis business medicine.drug |
| Zdroj: | Cleveland Clinic Journal of Medicine. 57:383-388 |
| ISSN: | 1939-2869 0891-1150 |
| DOI: | 10.3949/ccjm.57.4.383 |
| Popis: | Adenosine, recently released for the acute termination of supraventricular tachycardia, is potentially the drug of first choice for this indication. Its notable effects are transient slowing of the sinus rate and atrioventricular nodal block. Adverse effects are transient and clinically insignificant, primarily because of the ultra-short half-life of the drug. Preliminary investigations suggest that adenosine may also be useful in the differential diagnosis of wide Q R S complex tachycardias. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|